Core Insights - Nutex Health Inc. reported a significant financial performance for the three and nine months ended September 30, 2025, with a revenue growth of 225% and a record cash balance of $166 million [5][7]. Financial Highlights for Three Months Ended September 30, 2025 - Total revenue reached $267.8 million, a 239.9% increase from $78.8 million in the same period of 2024 [7]. - Hospital division revenue was $260.2 million, up 262.8% from $71.7 million in Q3 2024 [7]. - Net income attributable to Nutex Health was $55.4 million, compared to a net loss of $8.8 million in Q3 2024 [7]. - EBITDA for the quarter was $91.8 million, a 2014% increase from $4.3 million in Q3 2024 [7]. - Adjusted EBITDA was $98.5 million, compared to $9.7 million in Q3 2024 [7]. - Operating income improved to $130.4 million from $9.7 million in the same quarter of 2024 [7]. Financial Highlights for Nine Months Ended September 30, 2025 - Total revenue for the nine months was $723.6 million, a 225.5% increase from $222.3 million in the same period of 2024 [7]. - Net income attributable to Nutex Health was $59.0 million, compared to a net loss of $9.5 million in the first nine months of 2024 [7]. - EBITDA for the nine months was $142.9 million, a 616.4% increase from $19.9 million in the same period of 2024 [7]. - Adjusted EBITDA reached $243.0 million, compared to $16.1 million in the first nine months of 2024 [7]. - Total visits at the Hospital Division increased to 140,074, up 13.9% from 122,944 in the same period of 2024 [7]. Operational Insights - The company has a strong pipeline for future growth, reflecting continued demand for small hospitals across the country [6]. - Approximately 70% of hospital revenue was attributed to higher acuity claims and success through the Independent Dispute Resolution (IDR) process [7]. - The company has maintained a high collection rate of over 80% on legal determinations won through arbitration [7]. Compliance and Governance - Nutex Health has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the timely filing of its Form 10-Q for the period ended June 30, 2025 [9][10].

Core Insights - Nutex Health Inc. announced restated financial results for Q1 2025, highlighting significant growth in revenue and net income compared to the same period in 2024 [1][2][5] Financial Restatement - The Audit Committee concluded that previously issued financial statements for Q1 2025 required restatement due to non-cash adjustments, resulting in a net increase in liabilities by $19.6 million (4.0%) and a decrease in equity by $19.6 million (7.1%) [2][7] - Net income for Q1 2025 increased by $6.6 million (14.9%) to $21.2 million, with diluted earnings per share rising to $3.33 from $2.56 [2][6] Financial Highlights - Total revenue for Q1 2025 reached $211.8 million, a 214.0% increase from $67.5 million in Q1 2024 [6][8] - EBITDA for Q1 2025 was $51.5 million, up 624.7% from $7.1 million in Q1 2024, while adjusted EBITDA increased to $72.8 million from a loss of $0.4 million [6][8] - Net cash from operating activities was $51.0 million for Q1 2025, reflecting strong operational performance [6][8] Operational Performance - The number of patient visits increased by 20.5% to 48,269 in Q1 2025 compared to 40,068 in Q1 2024, with mature hospitals seeing a 5.3% increase in visits [8] - The company reported a record high gross profit margin of 55.9% and a cash balance of $84.7 million as of March 31, 2025 [5][8] Company Overview - Nutex Health operates 24 micro hospitals and outpatient departments across 11 states, focusing on integrated healthcare delivery [1][19] - The company is structured into two divisions: Hospital Division and Population Health Management Division, providing a range of healthcare services [19][20]

Core Viewpoint - Nutex Health Inc. will release its financial results for the second quarter ended June 30, 2025, on August 14, 2025, and will discuss these results in a conference call on August 15, 2025 [1]. Company Overview - Nutex Health Inc. is headquartered in Houston, Texas, and was founded in 2011. It operates as a healthcare management and operations company with two main divisions: Hospital Division and Population Health Management Division [3]. - The Hospital Division owns, develops, and operates innovative healthcare models, including 24 micro-hospitals across 11 states [3]. - The Population Health Management Division operates provider networks such as Independent Physician Associations (IPAs) and provides management and administrative support services through its Management Services Organization (MSO) [4].

Core Viewpoint - Nutex Health Inc. is actively engaging with investors through a Nasdaq bell-ringing ceremony and an investor meet and greet scheduled for August 26, 2025, highlighting its commitment to transparency and investor relations [1][2][3]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system, operating 24 micro hospitals and hospital outpatient departments (HOPDs) across 11 states [1][3]. - The company was founded in 2011 and is headquartered in Houston, Texas [3]. Divisions - The Hospital Division focuses on innovative healthcare models, including micro-hospitals and specialty hospitals, managing 24 facilities in 11 states [4]. - The Population Health Management Division operates provider networks such as Independent Physician Associations (IPAs) and offers management and administrative support services through its Management Services Organization (MSO) [5]. Event Details - The investor meet and greet will take place on August 26, 2025, from 9 am to 1 pm EST, with the location disclosed upon scheduling [2]. - The bell-ringing ceremony is scheduled for the same day at 3:45 pm EST, and it will be live-streamed [3].

Core Insights - Nutex Health Inc. has received multiple community-driven accolades for its healthcare delivery in the second quarter of 2025, highlighting its commitment to patient care and community service [1][2]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments across 11 states, focusing on primary care and risk-bearing physician networks [1][4]. - The company was founded in 2011 and is headquartered in Houston, Texas, operating through two divisions: Hospital Division and Population Health Management Division [4][5]. Awards and Recognition - The Colony ER Hospital was awarded "Best Urgent/Emergency Care" in April 2025 by The Colony Chamber of Commerce [3]. - Wylie ER received the title of "Best Emergency Room" in April 2025 from C&S Media [3]. - Dr. Michael Brin from Milwaukee ER & Hospital and Dr. Maley from Tucson ER & Hospital both received "Top Doc Awards" in June 2025 from respective local publications [3]. - Texarkana Emergency Center & Hospital was recognized for "Best Emergency Care/Hospital" in June 2025 by Bowie County Tribune and also received "Best Emergency Care" in the "2025 Best of Texarkana Readers' Choice Awards" [3]. - Dr. Tom Vo, the CEO of Nutex Health, was honored as "Most Admired CEO" in June 2025 by the Houston Business Journal [3]. Commitment to Patient Care - The company emphasizes that its recognition stems from a primary focus on patient care, with awards voted on by the communities it serves, reflecting high patient satisfaction and service quality [2][3].

Company Overview - Nutex Health Inc. is a physician-led, integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments (HOPDs) across 11 states [1][4] - The company operates two divisions: a Hospital Division and a Population Health Management Division [4][5] Recent Developments - Nutex Health has filed a supplement to its proxy statement on June 27, 2025, encouraging shareholders to review the new information [1] - The company's Annual Meeting of common stockholders is scheduled for July 14, 2025, at 10:00 am Central Time [2] Shareholder Information - Stockholders can access the definitive proxy statement dated June 2, 2025, and the Form 10-K online or request a free paper or email copy [2][3] - Instructions for requesting materials include visiting a specific website, calling a designated number, or sending an email with a control number [3]

Core Viewpoint - Nutex Health Inc. reported strong financial results for Q1 2025, showcasing significant growth in revenue, net income, and operational efficiency, driven by increased hospital visits and successful arbitration efforts [4][6]. Financial Performance - Total revenue for Q1 2025 reached $211.8 million, a 213.8% increase from $67.5 million in Q1 2024 [9]. - Net income attributable to Nutex Health was $14.6 million, compared to a net loss of $0.4 million in Q1 2024 [9]. - Diluted earnings per share (EPS) improved to $2.56 from $(0.08) in Q1 2024 [9]. - EBITDA for Q1 2025 was $43.1 million, a 507.0% increase from $7.1 million in Q1 2024 [9]. - Adjusted EBITDA was $72.8 million, compared to $(0.4) million in Q1 2024 [9]. Operational Highlights - Total hospital division visits increased by 20.5% to 48,269 in Q1 2025, up from 40,068 in Q1 2024 [9]. - Revenue from mature hospitals rose by 186.5% in 2025 compared to 2024 [9]. - The arbitration process contributed approximately $105.0 million in additional revenue, accounting for 73.1% of the total revenue increase [9]. Cash Flow and Balance Sheet - Net cash from operating activities was $51.0 million for Q1 2025 [9]. - As of March 31, 2025, total assets were $761.9 million, with cash and cash equivalents of $87.7 million [10]. - Long-term debt stood at $21.7 million [10]. Stock-Based Compensation - Total stock-based compensation expense for Q1 2025 was $36.1 million, significantly higher than less than $0.1 million in Q1 2024 [9].